156 related articles for article (PubMed ID: 16569081)
1. Thalidomide use in the US : experience with pregnancy testing in the S.T.E.P.S. programme.
Uhl K; Cox E; Rogan R; Zeldis JB; Hixon D; Furlong LA; Singer S; Holliman T; Beyer J; Woolever W
Drug Saf; 2006; 29(4):321-9. PubMed ID: 16569081
[TBL] [Abstract][Full Text] [Related]
2. S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide.
Zeldis JB; Williams BA; Thomas SD; Elsayed ME
Clin Ther; 1999 Feb; 21(2):319-30. PubMed ID: 10211535
[TBL] [Abstract][Full Text] [Related]
3. The return of thalidomide: can birth defects be prevented?
Lary JM; Daniel KL; Erickson JD; Roberts HE; Moore CA
Drug Saf; 1999 Sep; 21(3):161-9. PubMed ID: 10487395
[TBL] [Abstract][Full Text] [Related]
4. Challenges of thalidomide distribution in a hospital setting.
Keravich DP; Daniels CE
Am J Health Syst Pharm; 1999 Sep; 56(17):1721-5. PubMed ID: 10512502
[TBL] [Abstract][Full Text] [Related]
5. RevAssist: a comprehensive risk minimization programme for preventing fetal exposure to lenalidomide.
Castaneda CP; Zeldis JB; Freeman J; Quigley C; Brandenburg NA; Bwire R
Drug Saf; 2008; 31(9):743-52. PubMed ID: 18707189
[TBL] [Abstract][Full Text] [Related]
6. A drug repositioning success: The repositioned therapeutic applications and mechanisms of action of thalidomide.
Amare GG; Meharie BG; Belayneh YM
J Oncol Pharm Pract; 2021 Apr; 27(3):673-678. PubMed ID: 33249990
[TBL] [Abstract][Full Text] [Related]
7. [Thalidomide once more in the spotlight].
de Jong-van den Berg LT; Rutgers J; Cornel MC
Ned Tijdschr Geneeskd; 1998 Nov; 142(46):2509-12. PubMed ID: 10028338
[TBL] [Abstract][Full Text] [Related]
8. Ethical challenges of pregnancy prevention programs.
Bonebrake R; Casey MJ; Huerter C; Ngo B; O'Brien R; Rendell M
Cutis; 2008 Jun; 81(6):494-500. PubMed ID: 18666392
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide: 40 years on.
Diggle GE
Int J Clin Pract; 2001 Nov; 55(9):627-31. PubMed ID: 11770361
[TBL] [Abstract][Full Text] [Related]
10. The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine.
Knobloch J; Jungck D; Koch A
Curr Mol Med; 2017; 17(2):108-117. PubMed ID: 28429672
[TBL] [Abstract][Full Text] [Related]
11. The rehabilitation of thalidomide.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):26-33. PubMed ID: 11365029
[TBL] [Abstract][Full Text] [Related]
12. New cases of thalidomide embryopathy in Brazil.
Schuler-Faccini L; Soares RC; de Sousa AC; Maximino C; Luna E; Schwartz IV; Waldman C; Castilla EE
Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):671-2. PubMed ID: 17676592
[TBL] [Abstract][Full Text] [Related]
13. [Risk Management of Teratogenic Drugs ~The Current States of Practice in Europe, US and Japan~].
Takagi T; van Bennekom C; Amann S; Hattori C; Shirakuni Y; Sato T; Nasu M
Yakugaku Zasshi; 2015; 135(10):1161-8. PubMed ID: 26234426
[TBL] [Abstract][Full Text] [Related]
14. New concerns about thalidomide.
Ances BM
Obstet Gynecol; 2002 Jan; 99(1):125-8. PubMed ID: 11777522
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide and the Titanic: reconstructing the technology tragedies of the twentieth century.
Annas GJ; Elias S
Am J Public Health; 1999 Jan; 89(1):98-101. PubMed ID: 9987477
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention.
Brandenburg NA; Bwire R; Freeman J; Houn F; Sheehan P; Zeldis JB
Drug Saf; 2017 Apr; 40(4):333-341. PubMed ID: 28074423
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide Celgene Corp.
Bruyn GA
IDrugs; 1998 Aug; 1(4):490-500. PubMed ID: 18465584
[TBL] [Abstract][Full Text] [Related]
18. [Thalidomide: new uses for an old drug].
Wu KL; Sonneveld P
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
[TBL] [Abstract][Full Text] [Related]
19. The role of thalidomide in the management of erythema nodosum leprosum.
Walker SL; Waters MF; Lockwood DN
Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide in cutaneous lupus erythematosus.
Pelle MT; Werth VP
Am J Clin Dermatol; 2003; 4(6):379-87. PubMed ID: 12762830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
